Uterine Cancer

Overview

Experienced and caring specialists at Mayo Clinic are available to help you make informed decisions about the treatment of uterine cancer, including uterine sarcoma. Gynecologic surgeons, medical oncologists and radiation oncologists work closely to provide comprehensive assessment and formulate the best plan for each patient. At Mayo Clinic, patients have access to clinical trials offered exclusively or through cooperative groups such as the national Gynecologic Oncology Group. A physician will evaluate whether the patient's situation matches the requirements of the clinical trial.

Patients also have access to the resources of the Mayo Clinic Cancer Center. The National Cancer Institute has designated the Mayo Clinic Cancer Center a comprehensive cancer center in recognition of the superior depth and breadth of its capabilities.

Diagnosis

Mayo Clinic physicians conduct a pelvic exam and collect a medical history from the patient if uterine cancer is suspected. Other tests may include an ultrasound and a biopsy (the collection and examination of tissue) to gather cells from the uterus to test in the laboratory. Read more about diagnosis of uterine cancer.

Treatment Options

Often surgery is used to treat uterine cancer. Further treatment may include radiation, chemotherapy or hormone therapy. Read more about treatment options for uterine cancer.

• Treatment in Arizona
• Treatment in Florida
• Treatment in Minnesota

About Uterine Cancer

Enlarge

The uterus is a small, pear-shaped reproductive organ (womb) that sustains a baby during pregnancy. Common risk factors for uterine cancer include obesity, hypertension, excess estrogen, and a history of problems with ovulation. Endometrial cancer is the most common uterine cancer. It occurs in the organ's lining, the endometrium. Uterine sarcoma, which accounts for 5 percent of cases, involves the muscle of the uterus. Symptoms of endometrial cancer include bleeding not related to menstrual periods, unusual discharge, or pelvic pain. A majority of endometrial cancers are diagnosed in postmenopausal women ages 50 to 70 years.

Read more at
www.MayoClinic.com
A service of Mayo Foundation for Medical Education and Research